Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD

Blood (2017) 130 (Supplement 1): 5549.

https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549

Published: 2017

Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC

Blood (2017) 130 (Supplement 1): 2799.

https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799

Published: 2017

Journal Articles

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Moussab Damlaj, MD, Ghazi Samer, Giamal Edin Mohamed Gmati, MD, Walid Mashaqbeh, Mohsen Al Zahrani, MD, Khadega Ahmed Abuelgasim, MD, Mushtaq Rather, MD, Hend Salama, MD, Ahmed Askar, MD, Ayman Hejazi, MD

Blood (2016) 128 (22): 5787.

https://doi.org/10.1182/blood.V128.22.5787.5787

Published: 2016

Journal Articles

Role of FDG-PET/CT for Detection of Occult Bone Marrow Involvement in Patients from the Middle East and North Africa Region with Hodgkin Lymphoma

Moussab Damlaj, MD, Giamal Edin Mohamed Gmati, MD, Ghulam Syed, MD, Mohsen Al Zahrani, MD, Khadega Ahmed Abuelgasim, MD, Mushtaq Rather, MD, Salama Hend, MD, Hejazi Ayman, MD, Abdul-Rahman Jazieh, MD, Ahmed Askar, MD

Blood (2016) 128 (22): 5348.

https://doi.org/10.1182/blood.V128.22.5348.5348

Published: 2016

Journal Articles

The Hybrid Regimen of ABVD/BEACOPP May Overcome the High-Risk Features of the Advanced Stage Hodgkin Lymphoma

Ahmed Alaskar, MD, Ahmad Al Ameer, Gasmelseed Ahmed, MD, Ayman Alhejazi, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Mushtaq Rather, MD, Mohsen Al Zahrani, MD

Blood (2014) 124 (21): 5477.

https://doi.org/10.1182/blood.V124.21.5477.5477

Published: 2014

NARROW

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Role of FDG-PET/CT for Detection of Occult Bone Marrow Involvement in Patients from the Middle East and North Africa Region with Hodgkin Lymphoma

The Hybrid Regimen of ABVD/BEACOPP May Overcome the High-Risk Features of the Advanced Stage Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Role of FDG-PET/CT for Detection of Occult Bone Marrow Involvement in Patients from the Middle East and North Africa Region with Hodgkin Lymphoma

The Hybrid Regimen of ABVD/BEACOPP May Overcome the High-Risk Features of the Advanced Stage Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only